Brind.

Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.

2 reports, 2 independent Updated Aug 25
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
13
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.

Who's involved

What this event is mainly about
MarketDonald TrumpIntuitive SurgicalMedtronic plc

How it developed

Newest first. Tap a step to see who reported it.
  1. FDA approved Medtronic's Hugo robotic system for urological procedures, marking a major competitive shift in the medical device sector.Sub-event
  2. Market sentiment regarding growth rates turned disappointing for companies like Profound Medical on August 1, 2025.Sub-event
  3. Medtronic is developing a robotic-assisted surgery system that needs regulatory approval in the US, amidst aggressive trade policy threats.Sub-event
  4. Lemaitre, Intuitive Surgical, and Teleflex are identified as companies operating in the surgical equipment segment.Sub-event
  5. Medtronic invested in Orchestra BioMed's clinical programs and provided private placement funding, while Ligand also invested in the company.Sub-event
  6. Obagi Medical and Waldencast plc completed an acquisition expanding into dermal fillers and granting US rights to the Saypha line, while Trump-era tariffs benefit AI stocks.Sub-event
  7. Intuitive Surgical invested in Apreo Health, whose device competes with Zephyr Valve, which was previously approved by the FDA.Sub-event
  8. Goldman Sachs inquired about orthopedic market trends in August 2025.Sub-event
Show 5 earlier steps
  1. Medtronic plc affirmed its Q2 dividend of $0.71 per share and focused on expanding its PFA technology using the Hugo robotic platform for hypertension treatment.Sub-event
  2. Trump administration tariffs are a concern as Intuitive Surgical maintains market leadership in robotic-assisted surgery, viewed as a long-term investment.Sub-event
  3. Corporate activity in the medical device sector in August 2025 included Medtronic's shareholder changes, tariff impacts, and corporate shifts at Dentsply Sirona and Stryker.Sub-event
  4. Analyst firms Leerink Partners and Baird reiterated bullish stances and raised price targets for Intuitive Surgical.Sub-event
  5. Medical device market sees M&A, competition heats up, while Trump tariffs and FDA processes weigh on the sector.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • MedTech Dive4 medtech topics to watch for the rest of 2025 This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Halfway in
  • GlobeNewswireZimVie Reports Second Quarter 2025 Financial Results Recently entered into definitive agreement to be acquired by ARCHIMED for $19.00 in cash per share Net Sales from Continuing Operations of $116.7